Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,586.00    -8.00 (-0.17%)
Bid:
4,586.00
Ask:
4,590.00
Spread: 4.00 (0.087%)
Market Cap: £16.71b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Total Voting Rights

3 Jan 2025 11:51

RNS Number : 1134S
Coca-Cola HBC AG
03 January 2025
Β 

Coca-Cola HBC AG

Transfer of treasury shares and total voting rights

Β 

Zug, Switzerland - 3 January 2025 -Β Coca-Cola HBC AG ("Coca-Cola HBC") today announces in respect of the month ended 31 December 2024, the transfer of 27,121 ordinary shares of CHF 6.70 each ("Ordinary Shares") which are held in treasury shares out of treasury to cover the exercise of options granted under Coca-Cola HBC's share option plan.

Β 

Following the above, as of 31 December 2024, Coca-Cola HBC's issued share capital consisted of 373,239,562 Ordinary Shares, of which 7,620,541 Ordinary Shares are held by Coca-Cola HBC AG and 3,430,135 Ordinary Shares are held by its subsidiary, Coca-Cola HBC Services MEPE, in treasury. Accordingly, as of 31 December 2024, the total number of voting rights in Coca-Cola HBC is 362,188,886 for the purposes of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("DTRs").

Β 

Shareholders may use the above total voting rights figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Coca-Cola HBC under the DTRs.

Β 

This announcement is made in accordance with DTR 5.6.1.

Β 

Β 

EnquiriesΒ 

Coca-Cola HBC GroupΒ 

Investor and Analysts:Β 

Joanna KennedyΒ 

Former Head of Investor RelationsΒ 

Tel: +44 7802 427505

Β joanna.kennedy@cchellenic.com

Jemima BensteadΒ 

Head of Investor RelationsΒ 

Tel: +44 7740 535130Β 

jemima.benstead@cchellenic.comΒ 

Media:Β 

Sonia BastianΒ 

Head of CommunicationsΒ 

Tel: +41 7946 88054Β 

sonia.bastian@cchellenic.comΒ 

Claire Evans

Group Senior Communications Manager - Corporate

Β 

Tel:β€―+44 7597 562 978Β 

claire.evans@cchellenic.com

Β 

Β 

Β 

Β About Coca-Cola HBC

Β 

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

Coca-Cola HBC is listed on the London Stock Exchange (LSE: CCH) and on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com/

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TVRFXLFBEFLEBBB
Date   Source Headline
19th Mar 20251:25 pmRNSDirector/PDMR Shareholding
19th Mar 20251:00 pmRNSDirector/PDMR Shareholding
19th Mar 20251:00 pmRNSDirector/PDMR Shareholding
18th Mar 20251:21 pmRNSDirector/PDMR Shareholding
14th Mar 20253:45 pmRNSAnnual Financial Report
13th Mar 20252:18 pmRNSDirector/PDMR Shareholding
12th Mar 20259:22 amRNSDirector/PDMR Shareholding
11th Mar 202512:17 pmRNSDirector Declaration
5th Mar 20251:19 pmRNSDirector/PDMR Shareholding
4th Mar 20256:03 pmRNSTransfer of treasury shares and voting rights
4th Mar 20254:03 pmRNSDirector/PDMR Shareholding
26th Feb 202510:07 amRNSDirector/PDMR Shareholding
18th Feb 20251:50 pmRNSDirector/PDMR Shareholding
17th Feb 20259:22 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSStrong execution drove continued profitable growth
3rd Feb 202510:09 amRNSTransfer of treasury shares and voting rights
27th Jan 20253:13 pmRNSCorrection - Total voting rights
20th Jan 20251:49 pmRNSDirector/PDMR Shareholding
15th Jan 20251:55 pmRNSNotice of Results
3rd Jan 202511:51 amRNSTotal Voting Rights
2nd Jan 20259:16 amRNSDirector/PDMR Shareholding
18th Dec 20242:19 pmRNSDirector/PDMR Shareholding
17th Dec 20244:17 pmRNSDirector/PDMR Shareholding
17th Dec 20244:09 pmRNSDirector/PDMR Shareholding
17th Dec 20243:46 pmRNSHolding(s) in Company
4th Dec 202410:50 amRNSDirector/PDMR Shareholding
4th Dec 202410:28 amRNSDirector/PDMR Shareholding
2nd Dec 202410:35 amRNSTotal Voting Rights
29th Nov 20241:40 pmRNSDirector/PDMR Shareholding
29th Nov 202410:08 amRNSDirector/PDMR Shareholding
28th Nov 20248:41 amRNSDirector/PDMR Shareholding
28th Nov 20248:23 amRNSDirector/PDMR Shareholding
19th Nov 20243:51 pmRNSDirector/PDMR Shareholding
19th Nov 202411:14 amRNSFinal Terms - 2032 Notes
13th Nov 20244:41 pmRNSDirector Declaration
13th Nov 20244:11 pmRNSPricing of Issue of Notes
13th Nov 20248:39 amRNSIssue of Debt
12th Nov 20243:56 pmRNSPublication of Suppl.Prospcts
8th Nov 202410:27 amRNSNotice of purchase
7th Nov 202411:39 amRNSDirector/PDMR Shareholding
7th Nov 202411:36 amRNSDirector/PDMR Shareholding
1st Nov 202410:12 amRNSBlock listing Interim Review
31st Oct 20247:00 amRNSStrong execution drives continued growth
18th Oct 20243:36 pmRNSDirector/PDMR Shareholding
8th Oct 20241:06 pmRNSCCH holds webinar on Data, Insights and Analytics
4th Oct 20248:40 amRNSNotice of Results
1st Oct 20249:42 amRNSTotal Voting Rights
27th Sep 20245:17 pmRNSTransaction in Own Shares
26th Sep 20245:08 pmRNSTransaction in Own Shares
25th Sep 20245:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.